New Antihypertensive Stumbles in Phase 2 Study: HALO
But the study was marred by a large placebo effect and adherence issues, and so development of baxdrostat is continuing, researchers say.
Source: medscape.com
Page 14 - Deepak Bhatt News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Deepak Bhatt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Deepak Bhatt Today - Breaking & Trending Today
HALO: Baxdrostat No Better Than Placebo in Uncontrolled Hypertension
Trialists believe the results, at odds with the positive BrigHTN trial, stem from unexpected benefits in placebo-treated patients.
Source: tctmd.com
Elite athletes with genetic heart disease can safely return to play with diagnosis and treatment, early study suggests
In a new study, most elite athletes with a diagnosed genetic heart disease did not experience serious or fatal symptoms of their condition, such as sudden cardiac death. The research
Source: wktv.com
Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months
Six-month data had hinted at less efficacy in this subgroup, but just as in the main trial, longer follow-up boosted outcomes.
Source: tctmd.com
'Neuroprotectant' Drug Could Boost Outcomes After a Stroke
THURSDAY, Feb. 9, 2023 (HealthDay News) -- Using a "neuroprotectant" drug alongside the standard surgical removal of a clot may slash the risk of death and disability following a stroke,
Source: franklinfavorite.com